You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MTX

Showing 1 - 25 of 1,098
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Newly-diagnosed PCNSL Treated WithMethotrexate and

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023

Cesarean Scar Pregnancy Trial in Krakow (MTX monotherapy, MTX + letrozole add-on)

Active, not recruiting
  • Cesarean Scar Pregnancy
  • MTX monotherapy
  • MTX + letrozole add-on
  • Krakow, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Apr 29, 2023

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Paris, France
    Hôpital Pitié-Salpêtrière
Oct 24, 2022

Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

Completed
  • Rheumatoid Arthritis
  • Baotou, China
  • +19 more
Dec 5, 2022

SARS-CoV-2 Infection Trial in Nedlands (MTx-COVAB36, Placebo)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Jul 7, 2022

MTX and Its Metabolites Post Glucarpidase

Recruiting
  • Lymphoma
  • Acute Lymphatic Leukemia
  • HPLC/MS
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Jul 6, 2022

Recurrent Glioblastoma Trial (MTX110, Programmable pump and catheter system, Lomustine)

Recruiting
  • Recurrent Glioblastoma
  • Jacksonville, Florida
  • +1 more
Jan 26, 2023

Moderate and Severe RheumatoId Arthritis Trial in Beijing (Placebo plus MTX, RC18 160 mg plus MTX)

Active, not recruiting
  • Moderate and Severe RheumatoId Arthritis
  • Placebo plus MTX
  • RC18 160 mg plus MTX
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 9, 2022

TNFi as Monotherapy or Combination Therapy With MTX and Compare

Completed
  • Rheumatoid Arthritis
  • patterns of use of combination therapy and monotherapy
  • New York, New York
    Pfizer
Oct 7, 2022

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Tubal Pregnancy Unruptured Trial in Krakow (Letrozole as monotherapy, MTX as monotherapy)

Active, not recruiting
  • Tubal Pregnancy Unruptured
  • Letrozole as monotherapy
  • MTX as monotherapy
  • Krakow, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Apr 29, 2023

Rheumatoid Arthritis Trial (Natrunix with MTX (+folate), Natrunix with MTX (+folate))

Not yet recruiting
  • Rheumatoid Arthritis
  • Natrunix with MTX placebo (+folate)
  • Natrunix placebo with MTX (+folate)
  • (no location specified)
May 2, 2022

Medulloblastoma Trial in Houston (Treatment with MTX110)

Recruiting
  • Medulloblastoma
  • Treatment with MTX110
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 30, 2022

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))

Completed
  • Moderately to Severely Active Rheumatoid Arthritis
  • Jiujiang, Jiangxi, China
    Jiujiang No.1 peoples's hospital
May 4, 2022

Rheumatoid Arthritis Trial in Seoul (MTX)

Recruiting
  • Rheumatoid Arthritis
  • MTX
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 4, 2022

Uncontrolled Gout, Chronic Gout Trial in United States (Pegloticase and Methotrexate (MTX))

Recruiting
  • Uncontrolled Gout
  • Chronic Gout
  • Pegloticase and Methotrexate (MTX)
  • Anchorage, Alaska
  • +11 more
Dec 9, 2022

Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced

Completed
Has Results
  • Diffuse Intrinsic Pontine Glioma
  • Panobinostat Nanoparticle Formulation MTX110
  • Convection-Enhanced Delivery (CED)
  • San Francisco, California
    University of California, San Francisco
Feb 2, 2022

Rheumatoid Arthritis Trial in Porto (FBL-MTX, Placebo)

Completed
  • Rheumatoid Arthritis
  • Porto, Portugal
    BlueClinical Phase I
Nov 19, 2021

Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),

Recruiting
  • Rheumatoid Arthritis
  • +9 more
  • Recombinant Herpes Zoster Vaccine (RZV)
  • +5 more
  • São Paulo, Sao Paulo, Brazil
    Rheumatology Division of Hospital das Clínicas da Faculdade de M
May 24, 2023

Primary CNS Lymphoma Trial in Beijing (Orelabrutinib, Pomalidomide, Rituximab)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Beijing, Beijing, China
  • +2 more
May 19, 2022

Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022